Daniel J. Diekema - Concepedia

Author

Daniel J. Diekema

Also Known As

" Madison, Alan Zillich, Alexandre Marra, Christopher Moriates, D Diekema, D J Diekema, D. Diekema, D. J. Diekema, D.J Diekema, D.J. Diekema

585

Publications

40.8K

Citations

102

H-Index

185

Concepts

All Affiliations

University of Iowa University of Iowa Hospitals and Clinics JMI Laboratories Johns Hopkins University Centers for Disease Control and Prevention

About

Daniel J. Diekema is an author at University of Iowa specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	144	13.9K
2	Health Sciences	44	60	8.3K
3	Education	2	2	70
4	Engineering	2	2	49
5	Management	2	2	36

Daniel J. Diekema

269

Publications

29K

Citations

H-Index

Page 1

	Year	Citations
Survey of Infections Due to<i>Staphylococcus</i>Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999 Daniel J. Diekema, Michael A. Pfaller, Franz‐Josef Schmitz, Clinical Infectious Diseases Western Pacific RegionStaphylococcus AureusUnited StatesDrug ResistanceHealthcare-associated Infection	2001	1.4K
Attributable Mortality of Nosocomial Candidemia, Revisited Stephen H. Gillespie, Kyungwon Lee, Jeffery Vande Berg, Clinical Infectious Diseases	2003	1.1K
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 Michael A. Pfaller, Daniel J. Diekema, John Turnidge, Open Forum Infectious Diseases	2019	776
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion Michael A. Pfaller, Daniel J. Diekema, David L. Gibbs, Journal of Clinical Microbiology Fluconazole-r IsolatesAntifungal AgentAntimicrobial SusceptibilityHealth SciencesFungal Pathogen	2010	693
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo E. Mendes, Antimicrobial Agents and Chemotherapy	2019	612
International Surveillance of Bloodstream Infections Due to <i>Candida</i> Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones, Journal of Clinical Microbiology	2001	523
Methicillin-Resistant Staphylococcus aureus (MRSA) Strain ST398 Is Present in Midwestern U.S. Swine and Swine Workers Tara C. Smith, Michael J. Male, Abby L. Harper, PLoS ONE	2009	439
Antifungal Susceptibilities of <i>Candida</i> Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases Sandra S. Richter, Rudolph P. Galask, S. A. Messer, Journal of Clinical Microbiology	2005	417
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008 Michael A. Pfaller, David R. Andes, Daniel J. Diekema, PLoS ONE Path AllianceAntifungal AgentHealth SciencesFungal PathogenAntifungal Agents	2014	398
Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 Shawn R. Lockhart, Murray A. Abramson, Susan E. Beekmann, Journal of Clinical Microbiology Pathogenic MicrobiologyKlebsiella PneumoniaeEscherichia ColiAntibiotic ResistanceUnited States	2007	396

Page 1